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Potassium Current Increases 
Atrial Defibrillation Threshold by 
Favoring Post-Shock Re-Initiation
Brian O. Bingen1, Saïd F. A. Askar1, Zeinab Neshati1, Iolanda Feola1, Alexander V. Panfilov2, 
Antoine A. F. de Vries1 & Daniël A. Pijnappels1
Electrical cardioversion (ECV), a mainstay in atrial fibrillation (AF) treatment, is unsuccessful in up to 
10–20% of patients. An important aspect of the remodeling process caused by AF is the constitutive 
activition of the atrium-specific acetylcholine-dependent potassium current (IK,ACh → IK,ACh-c), which is 
associated with ECV failure. This study investigated the role of IK,ACh-c in ECV failure and setting the 
atrial defibrillation threshold (aDFT) in optically mapped neonatal rat cardiomyocyte monolayers. 
AF was induced by burst pacing followed by application of biphasic shocks of 25–100 V to determine 
aDFT. Blocking IK,ACh-c by tertiapin significantly decreased DFT, which correlated with a significant 
increase in wavelength during reentry. Genetic knockdown experiments, using lentiviral vectors 
encoding a Kcnj5-specific shRNA to modulate IK,ACh-c, yielded similar results. Mechanistically, failed 
ECV was attributed to incomplete phase singularity (PS) removal or reemergence of PSs (i.e. re-
initiation) through unidirectional propagation of shock-induced action potentials. Re-initiation 
occurred at significantly higher voltages than incomplete PS-removal and was inhibited by IK,ACh-c 
blockade. Whole-heart mapping confirmed our findings showing a 60% increase in ECV success 
rate after IK,ACh-c blockade. This study provides new mechanistic insight into failing ECV of AF and 
identifies IK,ACh-c as possible atrium-specific target to increase ECV effectiveness, while decreasing its 
harmfulness.
Atrial fibrillation (AF) is the most common cardiac arrhythmia in humans1. Over time, AF usually 
progresses from paroxysmal, to persistent and finally to permanent AF, partly due to the effect of AF on 
the arrhythmogenic substrate and/or progression of underlying structural heart disease2,3. While short 
self-terminating episodes of AF may remain asymptomatic, the occurrence of longer episodes is asso-
ciated with morbidity and mortality2,4–6. Hence, it is important to quickly convert AF to sinus rhythm 
in order to ameliorate symptoms and to prevent complications, but also to reduce AF-induced atrial 
remodeling leading to further AF progression. Consequently, termination of AF by electrical cardiover-
sion (ECV) remains the mainstay of acute AF treatment7,8.
While progression of AF increases the need for ECV, it is also an independent predictor of ECV fail-
ure9,10. ECV may fail to convert AF to sinus rhythm in as much as 10–20% of patients, although the rate 
of success also depends on the energy applied9,11. However, perpetually increasing the energy of ECV in 
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case of failure is undesirable, as this is associated with a progressive tendency for adverse events12,13. To 
improve acute AF treatment it is essential to increase the effectiveness of ECV and decrease the energy 
required for successful cardioversion, i.e. the atrial defibrillation threshold (aDFT).
A major aspect of the electrophysiological remodeling process associated with AF progression is the 
shortening of repolarization caused by (among other factors such as decreased L-type calcium current 
and increased inward rectifier potassium current) constitutive activity of the acetylcholine-dependent 
potassium current (IK,ACh → IK,ACh-c)14–17. Remodeling of IK,ACh-c may therefore play a pivotal role in the 
diminishing success of ECV with AF progression. IK,ACh is mediated by the Kir3.x family of potassium 
channels, which are expressed in the atria, but not in the ventricles18. As anti-arrhythmic drugs target-
ing ion channels shared between atria and ventricles have been shown to increase the burden of ven-
tricular arrhythmias19,20, modulation of IK,ACh-c (as a consequence of its atrial specificity) might provide 
the advantage of decreasing aDFT without risking alteration of ventricular electrophysiology. However, 
whether IK,ACh-c affects the ECV success rate and, if so, by which mechanism, remains to be elucidated. 
Therefore the effects of IK,ACh-c on ECV success rate in a 2D model of reentrant atrial tachyarrhythmias 
were investigated. Complementary experiments were performed in a whole-heart AF model. Selective 
inhibition of Kir3.x activity was accomplished using tertiapin or by lentiviral vector (LV)-mediated RNA 
interference (RNAi).
Results
IK,ACh-c blockade decreases aDFT. To test the hypothesis that IK,ACh-c affects the atrial defibrillation 
success rate or the aDFT, fibrillating atrial cardiomyocyte (aCMC) cultures were treated with tertiapin (a 
blocker of IK,ACh-c) before being subjected to electric shocks of 25–100 V in order to determine the DFT. 
Tertiapin treatment notably increased the success rate of defibrillation compared to untreated controls 
(from 36.3 to 80.0% at 50 V and from 91.0 to 100.0% at 100 V, Fig. 1d). The increase in success rate was 
accompanied by a significant decrease in DFT from 60.0 ± 25.1 V in control aCMC cultures (n = 33) to 
35.5 ± 10.9 V in tertiapin-treated aCMC cultures (n = 10; p < 0.05) (Fig. 1e).
IK,ACh-c blockade decreases aDFT by increasing wavelength. To elucidate the mechanisms by 
which IK,ACh-c blockade decreased the DFT, we first investigated the effects of tertiapin on several elec-
trophysiological parameters (i.e. conduction velocity [CV], action potential [AP] duration at 80% repo-
larization [APD80], wavelength, reentry cycle length and complexity). Tertiapin (n = 10) significantly 
increased APD80 in aCMCs during reentry (54.0 ± 20.7 vs 25.8 ± 4.6 ms in control cultures [n = 33]) 
(Supplemental Fig. 2A,B), in the absence of acetylcholine, confirming the presence of constitutively 
active IK,ACh in the aCMC cultures18. The CV during reentry was not significantly affected (9.5 ± 2.8 vs 
11.7 ± 2.9 cm/s in control cultures) (Supplemental Fig. 2A,C). Hence, the wavelength (determined by the 
product of APD and CV) was significantly increased by tertiapin treatment (0.48 ± 0.15 vs 0.30 ± 0.10 cm 
in control cultures) (Supplemental Fig. 2A,D). Through this increase in wavelength, IK,ACh-c blockade 
both caused a significant increase in reentry cycle length (106.2 ± 28.5 vs 61.9 ± 18.1 ms in control cul-
tures) (Supplemental Fig. 2A,E) and decrease in arrhythmia complexity (2.5 ± 3.5 vs 5.06 ± 5.06 PSs in 
control cultures) (Supplemental Fig. 2A,F).
Subsequently, DFT was plotted as a function of CV, APD80, wavelength, reentry cycle length or complex-
ity. As shown in Supplemental Fig. 3A, CV did not show any apparent relationship with DFT (R2 = 0.12). 
Furthermore, both reentry cycle length and APD80 displayed a weak inverse (hyperbolic-like) relationship 
with DFT (R2 = 0.24 and 0.34, respectively) (Supplemental Fig. 3B,C). DFT seemed to increase concord-
antly with the complexity of the arrhythmia, although this correlation was not very strong (R2 = 0.51, 
Supplemental Fig. 3D). In contrast, a more apparent relationship was found between wavelength and 
DFT, which showed an increase in DFT with decreasing wavelengths (R2 = 0.65, Supplemental Fig. 3E). 
Together, these results suggest that a blockade of IK,ACh-c decreases DFT through the resulting increase of 
the wavelength during reentrant tachyarrhythmias.
Effect of Kcnj5 knockdown on electrophysiological parameters and aDFT. To exclude the 
possibility that the DFT-lowering effect of tertiapin was caused by another mode of action than by its 
ability to block IK,ACh-c, Kcnj5 expression in aCMC cultures was specifically downregulated by RNAi 
using LV.Kir3.4↓ . After transduction with LV.Kir3.4↓ , Kir3.4 levels decreased to 36.5 ± 3.6% of those in 
LV.PpLuc↓ -transduced control cultures), as judged by Western blot analyses (Fig. 1f). Optical mapping 
of these cultures during reentry yielded similar results as obtained following tertiapin treatment, being a 
significant increase in APD80 (Supplemental Fig. 4A,B), a non-significant decrease in CV (Supplemental 
Fig. 4A,C) and a significant increase in wavelength (Supplemental Fig. 4A,D) and reentry cycle length 
(Supplemental Fig. 4A,E), while arrhythmia complexity significantly decreased (Supplemental Fig. 
4A,F). Importantly, also the DFT was significantly decreased by Kcnj5 knockdown (25.0 ± 3.5 [n = 14] 
vs 50.7 ± 19.4 V in LV.PpLuc↓ -transduced cultures [n = 13]) (Fig. 1g). Trends in the relationship between 
aDFT and CV, APD80, wavelength, reentry cycle length or complexity were similar to those found in the 
tertiapin experiments described in Supplemental Fig. 3 (data not shown).
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Successful defibrillation depends on forced PS removal. To investigate how an increase in wave-
length by IK,ACh-c blockade or Kcnj5 knockdown decreases aDFT, mechanisms of successful and failed 
defibrillation were studied.
During reentry, a continuous spatial progression of activation and phase around a PS (the point sur-
rounded by a complete cycle of phase [2π ])21 (Fig. 2a,b, left pictures) was observed, perpetuating both the 
PS and its consequent reentrant tachyarrhythmia. Following exposure of such a culture to a high-energy 
electric shock, this continuous spatial progression of activation was disturbed, through simultaneous 
depolarization of large areas of the culture (Fig. 2a, right picture; Fig. 2c, red arrow). As a consequence, 
the electrical shock forced all cells to the same phase of the AP (Fig. 2b, middle picture; Fig. 2d, red and 
green arrow), breaking the 2π phase convergence necessary for PS maintenance. Hence, after synchro-
nous repolarization (Fig. 2b, right picture; Fig. 2c) reentry was fully terminated (Supplemental Movie 1).
Concordantly, following exposure of a culture to a shock below the DFT, termination of the arrhyth-
mia failed as a consequence of incomplete synchronization of phases around a PS preventing its definitive 
removal. In these cases, the electrical shock still elicited simultaneous activation of large areas of the 
Figure 1. Model characterization and effect of IK,ACh-c modulation on aDFT. (a) Typical phase-contrast 
image of a confluent aCMC monolayer. (b) Snapshot of the spatial- and high-pass-filtered optical signal 
in an aCMC monolayer during 1-Hz pacing (left panel) showing a normal uniformly propagated convex 
wavefront, and after burst pacing displaying complex spiral wave reentry as a 2D model of AF (right panel). 
(c) Typical example of an oscilloscope output during a 40-V biphasic truncated exponential shock. Dashed 
line indicates the peak voltage of the first phase used in further analyses. Quantification of (d) percentage of 
successful defibrillation (DF) at 50 and 100 V and (e) atrial DF threshold (aDFT) in control and tertiapin-
treated cultures. (f) Western blot of Kir3.4 expression in LV.Kir3.4↓ -transduced aCMC cultures and in 
LV-PpLuc↓ -transduced control aCMC cultures using glyceraldehyde 3-phosphate dehydrogenase as loading 
control. M.W.M: molecular weight marker (numbers are in kDa). (g) Quantification of aDFT in aCMC 
cultures transduced with LV.PpLuc↓ or LV-Kir3.4↓ . *p < 0.05 vs control; #p < 0.05 vs LV.PpLuc↓ .
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cultures (Fig. 3a,c), perturbing the continuous spatial (Fig. 3a,b) and temporal (Fig. 3d) progression of 
activation and phase around the PS. However, tracking of the spatial and temporal phase progression 
showed incomplete synchronization of phase (point B in Fig. 3b,d) after the low-energy shock, causing 
PS persistence and failure of defibrillation (Supplemental Movie 2).
Figure 2. Successful defibrillation. (a,b) Typical activation (a) and phase (b) map sequence of an atrial culture 
exhibiting a single-rotor tachyarrhythmia prior to (left), during (middle) and after (right) exposure to an electric 
shock above the DFT. To simplify interpretation of the results, an example of limited complexity was chosen. 
The white arrows and circles indicate the direction of AP propagation and the location of the PS, respectively. 
+: side of first-phase cathode. –: side of first-phase anode. (c) Line analysis of “optical APs” (left) and filtered 
optical signals (right) (between points I and II in subfigure b) showing synchronization of depolarization 
after electrical shock application (indicated by the red arrow). Dashed white line indicates the position of 
the functional core of reentry. Color bar below the X-axis corresponds to that in subfigure a. (d) Plot of the 
phase at four points equally spaced around the PS (points A, B, C and D in subfigure b) prior to, during and 
after application of an electrical shock (indicated by the red arrow), showing completely asynchronous phase 
progression before but full synchronization of all phases (green arrow) after delivery of the electrical shock.
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Failed defibrillation caused by post-shock formation of PSs. Interestingly, application of elec-
trical shocks to aCMC cultures during fibrillation at voltages that eliminated all PSs present prior to the 
shock did not necessarily lead to successful defibrillation. In such instances, the gradual spatial progres-
sion of activation and phase present prior to shock (Fig.  4a,b, left pictures) was again interrupted by 
simultaneous activation of large areas of the culture, leading to phase synchronization and elimination 
of the existing PSs (Fig. 4b, middle picture; Fig. 4c,d, green arrows and Fig. 5a). However, if the shock 
strength was below DFT, new PSs formed in the culture prior to its full repolarization. The newly formed 
Figure 3. Failed defibrillation caused by incomplete PS removal. (a,b) Typical activation (a) and phase (b) 
map sequence of an atrial culture exhibiting a single rotor tachyarrhythmia prior to (left), during (middle) 
and after (right) exposure to an electrical shock below the DFT. To simplify interpretation of the results, 
an example of limited complexity was chosen. (c) Line analysis of “optical APs” and filtered optical signals 
(between points I and II in subfigure b) showing synchronization of depolarization during application 
of an electrical shock (indicated by the red arrow). (d) Plot of the phase at four points equally spaced 
around the PS (points A, B, C and D in subfigure b) prior to, during and after application of an electrical 
shock (indicated by the red arrow), showing asynchronous phase progression before and incomplete 
synchronization of all phases (green arrow), mainly at point B, after delivery of the electrical shock resulting 
in continued asynchronous phase progression. Symbols are equal to those in Fig. 2.
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PSs again gave rise to reentrant activation, reestablishing fibrillation in a different activation pattern 
(re-initiation), causing a failed defibrillation attempt (Fig.  4a,b, right pictures; Fig.  4c,d; Supplemental 
Movie 3).
Figure 4. Failed defibrillation caused by re-initiation. (a,b) Typical activation (a) and phase (b) map 
sequence of an atrial culture prior to (left), during (middle) and after (right) exposure to an electrical shock 
below DFT. (c) Plot of the phase at four points (A, B, C and D in subfigure b) equally spaced around a 
PS that is eliminated by the electrical shock and at four points (E, F, G and H in subfigure b) around a PS 
that emerges after electrical shock application (indicated by the red arrow). Points A, B, C and D showed 
asynchronous phase progression before and complete synchronization of all phases after delivery of the 
electrical shock (green arrow), followed by phase progression synchronized at points A and D and B and C 
due to AP propagation from a different PS. Before application of an electrical shock, points E, F, G and H 
showed phase progression synchronized at points E and H and F and G as a consequence of AP propagation 
from a nearby PS. Electrical shock delivery resulted in complete synchronization of all phases (green arrow) 
after which phase progression proceeded asynchronously as a consequence of a PS arising between these 
points. Symbols are equal to those in Fig. 2.
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Importantly, failure of defibrillation as a consequence of re-initiation was found to occur at signifi-
cantly higher voltages (e.g. closer to the DFT) than failure of defibrillation caused by failed PS removal 
(58.6 ± 21.6 vs 34.5 ± 8.2 V) (Fig.  5b). This indicates that of the mechanisms responsible for failed 
defibrillation, re-initiation is more important in setting the DFT. Together these results suggest that 
an increase in wavelength by IK,ACh-c blockade might decrease DFT by suppressing the occurrence of 
post-shock PS formation.
Mechanism of post-shock re-initiation. To elucidate the mechanism underlying post-shock forma-
tion of PSs ,we first subjected control atrial cultures (n = 10) to 25–100 V shocks without prior induction 
of reentry or electrical stimulation. In none of these cultures post-shock emergence of PSs was observed 
(Supplemental Fig. 5A,B), ruling out the shock protocol or configuration as a cause of post-shock 
re-initiation of reentry.
Next, we studied the repolarization of fibrillating control or tertiapin-treated cultures after applying 
shocks with a magnitude below the DFT established for control conditions (i.e. 30 V). This showed 
that the position of newly formed PSs co-localized with the steepest gradients in APD after the shock, 
with the post-shock reentrant wavefront moving from the area of latest towards to area of earliest 
repolarization (Fig. 6a). Dispersion in duration of the shock-induced AP was found to be significantly 
higher at the shortest pre-shock peak-to-post-shock peak intervals (PPIs) (Fig.  6b,d). IK,ACh-c blockade 
by tertiapin, did not prevent dispersion in repolarization of such shock-induced APs (Fig.  6c,d). In 
fact, post-shock APD dispersion in the tertiapin-treated cultures was significantly higher at diastolic 
intervals from 18–42 ms (Fig.  7d). Still, the maximal post-shock APD dispersion (i.e. at the shortest 
diastolic interval) did not significantly differ between control and tertiapin-treated cultures. Therefore, 
to actively assess the contribution of APD dispersion to re-initiation, we created permanent repolar-
ization heterogeneities in aCMC cultures, by transducing the left half of the cultures with LV.Kir3.4↓ 
(or LV.PpLuc↓ as control), while leaving the right half of the cultures untransduced as described in the 
Supplemental Material online (Supplemental Figs 6, 7). Interestingly, such spatially-defined downregu-
lation of Kir3.4 significantly lowered the defibrillation threshold (29.2 ± 4.6 vs 41.1 ± 13.5 V in hetero-
geneously PpLuc↓ -transduced control cultures) (Supplemental Fig. 7F). Moreover, analysis of the area 
of first activation after applying shocks below the DFT showed that these sites were only found in the 
Figure 5. The relative role of re-initiation in failed defibrillation. (a) Line analysis of “optical APs” 
(left) and filtered optical signals (right) showing synchronization of depolarization during application of 
an electrical shock (indicated by the red arrow). Points I and II correspond to points I and II in Fig. 4b. 
Dashed white lines indicate the positions of the functional cores of reentry. Color bar below the X-axis 
corresponds to that in Figure 5a. (b) Quantification of the maximal voltage during a 25–100 V incremental 
shock protocol at which defibrillation failed because of failed phase singularity (PS) removal or post-shock 
PS formation leading to re-initiation of reentry. *p < 0.05 vs failed synchronization.
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untransduced part (area I) of LV.Kir3.4↓ -transduced aCMC cultures (n = 10) (Supplemental Fig. 7G). In 
comparison, in LV.PpLuc↓ -treated cultures, no clear preference in re-initiation site was found, i.e. 40% 
of the first post-shock APs originated in the untransduced area (area I) vs 10% and 20% in the border 
area (area II) and transduced area (area III), respectively; n = 10) (Supplemental Fig. 7G). Together these 
results suggest that re-initiation and prevention of re-initiation by IK,ACh-c inhibition are not driven by 
repolarization heterogeneities in our model.
Subsequently, to actively assess the role of shock-induced depolarization in re-initiation, we quantified 
the effect of the PPI on the amplitude of the shock-induced APs at 30 V (i.e. below the average DFT) and 
at 90 V (i.e. above the average DFT) during fibrillation. Shock-induced AP amplitudes were significantly 
higher at 90 V than at 30 V (Supplemental Fig. 8A). The shock-induced AP amplitude diminished signif-
icantly with decreasing PPIs at both voltages (Supplemental Fig. 8A). Interestingly, 90-V shocks flattened 
the curve of the relationship between PPI and amplitude in comparison to 30-V shocks (n = 6 cultures 
per group), attributable to its increased effect on relative refractory tissue at short PPIs. Concordantly, 
in the absence of reentry or prior to electrical stimulation there was no difference in the AP amplitude 
induced by a 30 or 90 V shock (Supplemental Fig. 8B, n = 6 cultures per group), while the functional 
core of the reentrant spiral waves did not affect shock-induced depolarization (as judged by the effect of 
distance to the PS on the local shock-induced AP amplitude, Supplemental Fig. 8C, n = 6 cultures per 
group).
Importantly, the areas of PS emergence after the electrical shock also co-localized with the (bor-
ders of) areas of lowest shock-induced AP amplitude (i.e. at the areas with the shortest PPIs) (Fig. 7a), 
with conduction of the shock-induced AP wavefront directed from highly depolarized towards the 
incompletely depolarized regions (Fig.  7a,d). Tertiapin did not significantly affect the shock-induced 
AP amplitude (Fig. 7c). However, similar to high voltage shocks, tertiapin treatment showed a trend to 
flatten the curve of the relationship between PPI and shock-induced AP amplitude (Fig. 7c). Moreover, 
Figure 6. Repolarization heterogeneities and failed defibrillation. (a) Map of AP duration until 80% 
repolarization (APD80) (left panel) of the shock-induced AP and phase map (right panel) of a control 
culture directly after electrical shock delivery, showing that the locations of the steepest APD/repolarization 
gradients co-localize with the areas of PS formation directly after the shock. The magnified area (red square) 
of the repolarization map (upper right panel) indicates the APDs and the direction of AP propagation going 
from the area of latest repolarization towards the area of earliest repolarization (white arrow). (b) Overlay 
of the areas with 6- to12-ms PPIs (grey hatching) and the APD80 map, showing that areas of steep APD 
gradients fall in the areas with the shortest PPIs. (c) Repolarization map (left panel) of the shock-induced 
AP in a tertiapin-treated culture. (d) Quantification of APD80 dispersion of APs induced by 30-V electrical 
shocks in tertiapin-treated and control cultures at PPIs of 12 to 42 ms.
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at areas of heterogeneous shock-induced depolarization in tertiapin-treated cultures, the shock-induced 
AP wavefront blocked on the refractory tail of the pre-shock activation, as a consequence of the 
tertiapin-dependent increase in wavelength (Fig. 7e).
Taken together, these results suggest that failed defibrillation through re-initiation is caused by 
heterogeneous depolarization as a consequence of impaired tissue depolarization at short PPIs. This 
causes steep post-shock membrane potential gradients, which allow unidirectional propagation of the 
shock-induced AP in these critical areas. IK,ACh-c blockade blunts the heterogeneity in depolarization 
induced by low-voltage shocks and inhibits the unidirectional propagation of shock-induced APs by 
increasing wavelength, which prevents re-initiation and lowers DFT.
Figure 7. Depolarization heterogeneities and failed defibrillation. (a) Map of the amplitude of the shock-
induced AP without (left panel) or with an overlay of the areas with 6- to 12-ms PPIs (grey hatching; middle 
panel) and the phase map of a control culture directly after delivery of a 30-V electrical shock, showing co-
localization of short PPIs, low shock-induced AP amplitudes and sites of post-shock PS emergence. (b) Map of 
the amplitude of the shock-induced AP of a tertiapin-treated culture. (c) Quantification of the shock-induced 
AP amplitude in control and tertiapin-treated cultures at PPIs between 12 and 42 ms. (d) Filtered optical 
signals between points I and II depicted in subfigure (a), showing impaired shock-induced depolarization near 
point II, leading to propagation of the shock-induced AP wavefront towards point II (direction indicated by 
blue arrow and white arrow in A). (e) Filtered optical signals between points I and II depicted in subfigure 
(b), showing block of conduction (indicated by double blue lines and double white lines in A) of the shock-
induced AP wavefront on the repolarizing waveback of the pre-shock activation between areas of large and 
impaired shock-induced depolarization.
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Effect of IK,ACh-c blockade in whole-heart electrical cardioversion. As many of the events investi-
gated in the present study may occur subepicardially in the whole heart, our 2D AF model allowed us to 
obtain unique insights into the mechanisms determining aDFT. However, to confirm the aDFT lowering 
effect of IK,ACh-c blockade in the more complex and clinically relevant 3D setting, we studied the effect 
of IK,ACh-c blockade by tertiapin during whole-heart mapping (Fig. 8a). Indeed, using the lowest defibril-
lation energy (30 V), failed defibrillation was observed in control hearts. Re-initiation of fibrillation was 
a major mechanism of failed defibrillation, because a notable change in cycle length could be observed 
after the electrical shock, suggesting that a different reentrant pathway maintained subsequent fibrilla-
tion (Fig. 8b). Following tertiapin treatment, hearts displayed a strong increase in atrial APD and cycle 
length after AF induction (Fig. 8c), and showed termination of AF by ECV at the lowest voltage (30 V). 
As expected from the in vitro experiments, tertiapin evidently decreased the ECV threshold (36.1 ± 11.3 
vs 27.2 ± 0.66 V in untreated control hearts) (Fig. 8d), while the success rate of ECV at 30 V shocks was 
increased by 60% (100% vs 40% in control hearts) (Fig. 8e). Together, these results support the notion 
that IK,ACh-c increases ECV threshold and decreases success rate of atrial defibrillation in the whole heart.
Discussion
Key findings of this study are: (1) Pharmacological blockade of IK,ACh-c in neonatal rat aCMC cultures or 
intact atria exhibiting persistent spiral waves of electrical activity, results in a significant increase in the 
Figure 8. Ex vivo confirmation of the role of IK,ACh-c in determining aDFT. (a) Example of a neonatal rat 
heart in the ex vivo mapping setup, prior to commencing the AF induction protocol. Typical ventricular 
(V) and atrial (b) single-pixel recordings of (b) a control (n = 6, 16.7% non-inducible) and (c) a tertiapin-
treated (n = 7, 57.1% non-inducible) heart. Red arrows indicate the moment of electrical shock application. 
Notice the increase in atrial activation frequency following electrical shock application in the control heart. 
Quantification of (d) atrial defibrillation threshold (aDFT) and (e) electrical cardioversion (ECV) success 
rate following delivery of a 30-V electrical shock in control and tertiapin-treated hearts. a.u.: arbitrary units.
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wavelength of reentry and decrease in the energy required for electrical defibrillation (i.e. a decreases 
in aDFT). Similar results were obtained after RNAi-mediated downregulation of one of the molecular 
correlates of IK,ACh-c, Kir 3.4. (2) IK,ACh-c inhibition lowers aDFT by preventing post-shock arrhythmia 
re-initiation following defibrillation attempts with low voltage shocks. (3) Mechanistically, blockade of 
IK,ACh-c moderates the spatial shock-induced differences in depolarization and prevents propagation of 
the shock-induced AP wavefront, through the increase in wavelength. (4) Finally, IK,ACh-c may serve as 
a target for lowering the energy requirements for ECV and increasing its effectiveness, without altering 
ventricular electrophysiology, thereby limiting the harmfulness of (pharmacologically assisted) ECV.
AF is known to be a progressive disease; patients with paroxysmal AF therefore often develop per-
sistent or even permanent AF2,3. The underlying principle of AF begetting AF, is one of the reasons for 
applying cardioversion in AF patients. Moreover, with disease progression, increasing amounts of energy 
may be required for successful ECV and patients with permanent AF may ultimately become refractory 
to cardioversion9,10,22. As the success rate of ECV already decreases after 24 h of AF22, this decrease is 
likely (at least partially) attributable to electrical remodeling (as opposed to its structural counterpart). In 
this study, we have elaborated on the effect of electrical remodeling on ECV success rate. We show that 
IK,ACh-c, as a constituent of this remodeling, is a sufficient cause for an increase in aDFT and a decrease 
in ECV success rate. Since the molecular components of IK,ACh-c are absent in the ventricles, blockade of 
IK,ACh-c might provide an atrium-specific target to facilitate successful ECV of AF without increasing the 
risk of ventricular pro-arrhythmia, thereby adding to the significance of our results.
According to present theories, defibrillation will fail if the portion of the myocardium that is excited 
or rendered refractory by the electrical shock is too small to effectively cause termination of all reentrant 
conduction23,24. Indeed, the present study confirms that exciting a critical portion of the myocardium 
is essential for successful defibrillation. If the shock strength is too low to meet this requirement, the 
consequent incomplete synchronization of the gradual progression of phase around the PS will lead to 
its continued existence and thereby to ineffective defibrillation. However, we show that close to the DFT, 
failure of electrical shocks to defibrillate may occur even if their strength is enough to cause elimination 
of all pre-existing PSs25–27. Here, post-shock formation of PSs is the underlying cause of defibrillation 
failure. Hence, extinguishing the wavefronts that perpetuate fibrillation through synchronous depolari-
zation is necessary but not sufficient for successful defibrillation.
While other studies, mostly focusing on ventricular fibrillation, have postulated re-initiation of fibril-
lation as an important mechanism of defibrillation failure of electrical shocks near the DFT, controversy 
remains regarding the origin of post-shock re-initiation. The presence of an isoelectric window after a 
failed defibrillation shock (i.e. the temporal gap between the application of a shock and the observation 
of first epicardial activation) was the first clue that led to the introduction of the theories postulating 
re-initiation of reentry to underlie defibrillation failure27. Because of this gap it has been hypothesized 
that the re-initiation of (ventricular) fibrillation could be caused by triggered activity resulting from early 
(EADs) or delayed afterdepolarizations (DADs)28. In the present study post-shock EADs and DADs were 
not observed. Moreover, APD prolongation was shown to prevent post-shock re-initiation of reentrant 
activity. If in our case formation of the first PS after the electrical shock would depend on phase-2 EADs, 
APD prolongation would increase the chance for re-initiation as well as the DFT. However, APD prolon-
gation does decrease the susceptibility for post shock late phase-3 EADs and DADs27. Still, in contrast 
to our findings, these phenomena are associated with long isoelectric windows or immediate recurrence 
of AF (IRAF) after primary ECV success29. Our results therefore suggest that afterdepolarizations are an 
unlikely cause of defibrillation failure in AF. Given the rapid reappearance of fibrillatory electrical activity 
after unsuccessful ECV (Figs 5 and 8), the isoelectric window in whole hearts could be attributable to 
intramural reentry occurring before activation becomes measurable at the epicardium.
In theory, the origin of re-initiation could also be the electrical shock itself. Several studies showed 
that when exposed to external field stimulation, areas of cardiac tissue can be either excited (i.e. the 
virtual cathode) or de-excited (i.e. the virtual anode)30,31. The latter causes AP shortening, which restores 
excitability in the de-excited area26,32. As a consequence of electrotonic interaction between the depolar-
ized and the hyperpolarized area (i.e. break excitation)33. new wavefronts can be formed and propagated 
in the direction of the excitable de-excited area after the shock, potentially creating new reentrant circuits 
that cause shock failure26,34.
In the present study, de-excitation was far less apparent (although small areas of APD shortening were 
observed, analogous to virtual anodes). As tissue heterogeneity may be a determinant of the occurrence 
of virtual electrode polarization35,36, this difference may, in part, be attributed to the homogeneous nature 
of our cell culture model. More importantly, virtual electrode polarization may be prevented by the use 
of a biphasic shock, as utilized in our study. The second phase of a biphasic shock is thought to quickly 
re-excite the de-excited area, while only partially de-exciting the excited area, homogenizing post-shock 
polarization26. As such, the effectiveness of the biphasic shock in preventing virtual electrode formation 
depends on the amplitude of the second phase relative to that of the first phase. In the present study, 
the peak voltage of the second phase was 20% of the maximum voltage in the first phase, which has 
been previously shown to cause effective asymmetric reversal of the polarity in the first phase, thereby 
preventing virtual electrode formation26.
Moreover, according to the virtual electrode hypothesis of defibrillation strong shocks can prevent 
virtual electrode polarization and re-initiation by enlarging the areas of complete de-excitation. If a 
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wavefront is formed by break excitation, this wavefront will promptly excite the de-excited area as a con-
sequence of its local shock-induced gain in excitability. As this fast excitation does not allow for recovery 
of the virtual cathode area, new reentrant circuits are prevented32. In our model, strong shocks do not 
increase de-excitation (again as a consequence of its biphasic nature), but increase the amount of excited 
tissue (that would have been refractory to low shock voltages). As a consequence post-shock polarization 
is homogenized, which prevents re-initiation. Similarly, tertiapin decreases the steepness in the relation-
ship between the shock-induced AP amplitude and the PPI, which also homogenized post-shock polar-
ization. Simultaneously, tertiapin increases refractoriness in incompletely depolarized areas and hence 
prevents propagation of wavefronts initiated at depolarized areas, which together decrease DFT. Hence, 
our paper shows that DFT can be decreased through other means than by increasing de-excitation, in the 
context of a biphasic shock. Still, mechanisms of re-initiation found in our study are largely analogous to 
the virtual electrode hypothesis being dependent heterogeneous polarization.
Finally, the critical point hypothesis of defibrillation states that reentry can initiate at critical junctions 
between the shock-induced extracellular potential gradient and the refractoriness gradient caused by the 
last pre-shock activation37. The present study confirms that re-initiation of AF depends on local tissue 
refractoriness. It should be noted, however, that the critical point hypothesis stems from experiments 
in which a monophasic S2 shock was given during phase 2 or 3 of the AP from a plane perpendicular 
to that of the S1 shocks, causing potential and refractoriness gradients to cross each other28,37. Applying 
biphasic shocks during fibrillation, should partly resolve the potential gradient, and cause the refracto-
riness to be dispersed. At variance with the critical point hypothesis, in our model formation of critical 
points (i.e. post-shock PSs) occurred in the area of highest refractoriness (i.e. the shortest PPI), instead 
of remote from this area.
The fact that most of the current theories about cardiac fibrillation and defibrillation mechanisms 
come from the field of ventricular fibrillation and can only partly explain our findings, may also indicate 
that different mechanisms might be responsible for defibrillation failure in ventricular fibrillation and 
AF, underlining the novelty of our results.
In this study, we utilized models of AF in which tachyarrhythmic activation after burst pacing relies 
on reentrant activity. As focal mechanisms may also underlie fast activation during AF38, the energy 
necessary to eliminate AF of focal origin, as well as the effect of diminishing IK,ACh-c, on the efficiency 
with which such an arrhythmia can be terminated may be different from what was found in the present 
study. Still, it should be noted that reentrant re-initiation at critical PPIs can also occur after eliminating 
a focal source by electrical shock. Hence, in this case a protective effect of IK,ACh-c might be expected. 
Further studies will be necessary to explore this possibility.
In addition, ECV in the clinical setting not only fails because of true shock failure but also by IRAF 
in which, after the electrical shock, one or more sinus beats are followed by re-initiation of AF39. Only 
the true shock failure aspect of ECV failure has been investigated in the present manuscript. Since the 
mechanisms for true shock failure and IRAF may differ, blockade of IK,ACh-c might not prevent ECV 
failure due to IRAF. Nonetheless, we and others have shown that IK,ACh-c blockade can also prevent the 
initiation of AF18,40.
The use of neonatal rat aCMC monolayers allowed us to systematically study the mechanisms of 
AF in the context of IK,ACh-c inhibition in a controllable environment. These monolayers are, however, 
inherently different from intact human atria because of their 2D nature and the electrophysiological 
differences between human and rat aCMCs. Nonetheless, results obtained in our 2D model were repro-
duced in intact hearts, confirming its relevance. Due to the minute dimensions of the intact neonatal rat 
heart, crosstalk between the ventricular and atrial optical signal was observed during optical mapping. 
Still, presence or absence of AF is easily derived from the obtained atrial signal. As a consequence of this 
crosstalk, no analyses on post-shock reinitiation mechanisms were performed in the whole heart. Hence, 
we concur that the results of this study are conceptual with respect to ECV in humans and therefore 
cannot be readily extrapolated to the clinical setting.
Conclusions
This is the first study to systematically study the role of the IK,ACh-c in atrial defibrillation. The results 
indicate that remodeling of this current, as occurs during AF, can contribute to an increase in aDFT and 
failure of ECV. Hence, IK,ACh-c may serve as an interesting target for lowering the energy requirements for 
ECV and increasing its effectiveness, without altering ventricular electrophysiology, limiting the harm-
fulness of (pharmacologically assisted) ECV.
Methods
A detailed description of materials and methods can be found in the Supplementary Material online.
All animal experiments were approved by the Animal Experiments Committee of the Leiden 
University Medical Center and conformed to the Guide for the Care and Use of Laboratory Animals as 
stated by the US National Institutes of Health.
Preparation of aCMC monolayers. Neonatal rat aCMCs were isolated by collagenase digestion and 
cultured on 15-mm-diameter fibronectin-coated coverslips as described previously18. A cell density of 
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8 × 105 cells/well in 24-well culture plates was maintained throughout the experiments by restricting 
proliferation (of non-myocytes) through treatment with Mitomycin-C (Sigma-Aldrich, St. Louis, MO) 
at day 1 of culture.
RNAi. Self-inactivating lentiviral vectors encoding enhanced green fluorescent protein (eGFP) and a 
shRNA specific for rat Kcnj5 (LV-Kir3.4↓ ) or for Photinus pyralis luciferase (LV-PpLuc↓ , negative control 
vector) were generated as described in detail in the Supplementary Material online. Transduction was 
performed at day 4 of culture. Knockdown of Kir3.4 after transduction with LV-Kir3.4↓ was confirmed 
using Western blot.
Optical mapping. High resolution optical mapping was performed at day 9 of culture using 
di-4-ANEPPS (Life Technologies) as a voltage-sensitive dye and a MiCAM ULTIMA-L imaging system 
(SciMedia, Costa Mesa, CA) as described previously18. For 1-Hz or burst pacing of confluent aCMC 
cultures (Fig. 1a), a custom epoxy-coated bipolar electrode was used, resulting in normal convex waves 
(Fig.  1b, left picture) or reentrant spiral waves (Fig.  1b, right picture), respectively. Defibrillation was 
performed using a custom electroshock module (Supplemental Fig. 1A), which was coupled to two plat-
inum electrodes fixed in a plastic ring that was readily mountable to the top of a 24-well culture plate. 
Electrodes were 9-mm in length, placed parallel 11-mm apart, and 2 mm above the surface of the cul-
ture (Supplemental Fig. 1B–D). This setup produced biphasic truncated exponential shocks of adjustable 
voltages (≈ 25–105 V) with the second-phase peak voltage being 20% of the first-phase peak voltage 
(Fig. 1C). DFT was defined as the voltage used during the first shock (starting from ≈ 25 V and progres-
sively increasing with 10-V increments) leading to full elimination of arrhythmic activity.
To assess the effect of IK,ACh-c blockade on defibrillation, tertiapin (100 nM) was pipetted in the 
medium and dispersed by gentle agitation, directly followed by optical mapping.
Whole heart di-4-ANEPPS-mapping was performed on neonatal rat hearts suspended in a 16-mm 
diameter tissue bath. Hearts were perfused with oxygenated Tyrode’s solution (comprising [in mM] NaCl 
130, CaCl2 1.8, KCl 4.0, MgCl2 1.0, NaH2PO4 1.2, NaHCO3 24 and glucose 5.5 at pH 7.4) supplemented 
with 20 mM 2,3-butanedione monoxime (Sigma-Aldrich) to minimize motion artifacts. The burst pac-
ing, electrical shock protocol and electrode setup (mounted to the tissue bath) used to determine the 
aDFT were equal to those used in the in vitro experiments.
Statistics. Statistical analyses and construction of corresponding graphs were performed using 
Graphpad Prism 6.0 (Graphpad Software, San Diego, CA). Comparison between two groups was per-
formed using the non-parametric Mann-Whitney U test (for unpaired measurements) or Wilcoxon 
signed rank (for paired measurements) test. Kruskall-Wallis testing with Bonferoni post-hoc correc-
tion was used for multiple groups and comparisons. Data were expressed as mean ± standard deviation 
(SD) for a number (n) of observations. Differences were considered statistically significant if p < 0.05. 
Non-linear regression curves were constructed by using a robust exponential two-phase decay curve fit. 
Accuracy of these curves was expressed as the coefficient of determination (R2).
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